Studies on endogenous neuronal mediator with responsibility for anti-dementia effect of Kampo medicine

  • 松本, 欣三 (Principal Investigator)
  • 常山, 幸一 (Co-Investigator(Kenkyū-buntansha))
  • 田中, 謙 (Co-Investigator(Kenkyū-buntansha))
  • 村上, 幸寿 (Co-Investigator(Kenkyū-buntansha))
  • 柴原, 直利 (Co-Investigator(Renkei-kenkyūsha))

Project Details

Abstract

In this study, we have demonstrated the anti-dementia effects of chotosan, yokukansan, and kangenkaryu using animal models of cognitive deficits. We have also suggested that vascular endothelial growth factor and platelet-derived growth factors, as well as facilitation of central cholinergic systems and neuroplasticity systems, are involved in the action of these crude drugs. The present findings that VEGF/PDGF and their receptors are co-localized with NMDA-type glutamate receptors in the cerebral cortical neurons allowed us to infer that VEGF/PDGF may act as endogenous factors that mediate the anti-dementia effects of chotosan, kangen-karyu, and yokukansan.
StatusFinished
Effective start/end date2008/01/012010/12/31

Funding

  • Japan Society for the Promotion of Science: ¥18,980,000.00

Keywords

  • 認知症モデル
  • 漢方薬
  • メディエータ
  • 脳虚血
  • 加齢
  • dementia model
  • Kampo medicine
  • vascular endothelial growth factor
  • neuroplasticity
  • aging
  • platelet derived growth factor
  • ischemia
  • mediator(s)
  • anti-dementia drug
  • emotional disoders
  • Senescence-accelerated mouse